Matrix Protein of Cell-associated Subacute Sclerosing Panencephalitis Viruses

References

1. Baczko K., Carter M. J., Billeter M., Ter Meulen V. 1984; Measles virus gene expression in subacute sclerosing panencephalitis. Virus Research 1:585–595
   [Google Scholar]
2. Bellini W. J., Englund G., Rozenblatt S., Arnheiter H., Richardson C. D. 1985; Measles virus P gene codes for two proteins. Journal of Virology 53:908–919
   [Google Scholar]
3. Bellini W. J., Englund G., Richardson C. D., Rozenblatt S., Lazzarini R. A. 1986; Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. Journal of Virology 58:408–116
   [Google Scholar]
4. Breschkin A. M., Morgan E. M., Mckimm J., Rapp F. 1979; SSPE-BIKEN: a naturally arising hemagglutination-defective mutant of measles virus. Journal of Medical Virology 4:67–80
   [Google Scholar]
5. Carter M. J., Willcocks M. M., Ter Meulen V. 1983; Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature London: 305153–155
   [Google Scholar]
6. Cattaneo R., Schmid A., Rebmann G., Baczko K., Ter Meulen V., Bellini W. I., Rozenblatt S., Billeter M. A. 1986; Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 154:97–107
   [Google Scholar]
7. Cattaneo R., Schmid A., Billeter M. A., Sheppard R. D., Udem S. A. 1988; Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. Journal of Virology 62:1388–1397
   [Google Scholar]
8. Curran M. D., Rima B. K. 1988; Nucleotide sequence of the gene encoding the matrix protein of a recent measles virus isolate. Journal of General Virology 69:2407–2411
   [Google Scholar]
9. Doi Y., Sampe T., Nakajima M., Okawa S., Katoh T., Itoh H., Sato T., Oguchi K., Kumanishi T., Tsubaki T. 1972; Properties of a cytopathic agent isolated from a patient with subacute sclerosing panencephalitis in Japan. Japanese Journal of Medical Science and Biology 25:321–333
   [Google Scholar]
10. Hall W. W., Choppin P. W. 1979; Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology 99:443–47
    [Google Scholar]
11. Hall W. W., Lamb R. A., Choppin P. W. 1979; Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proceedings of the National Academy of SciencesU.S.A. 76:2047–2051
    [Google Scholar]
12. Lin F. H., Thormar H. 1980; Absence of M protein in a cell-associated subacute sclerosing panencephalitis virus. Nature London: 285490–492
    [Google Scholar]
13. Machamer C. E., Hayes E. C., Zweerink H. J. 1981; Cells infected with a cell-associated subacute sclerosing panencephalitis virus do not express M protein. Virology 108:515–520
    [Google Scholar]
14. Maniatis T., Fritsch E. F., Sambrook J. 1982; Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
15. Mirchamsy H., Bahrami S., Shafyi A., Shahrabady M. S., Kamaly M., Ahourai P., Razavi J., Nazari P., Derakhshan I., Lotfi J., Abassioun K. 1978; Isolation and characterization of a defective measles virus from brain biopsies of three patients in Iran with subacute sclerosing panencephalitis. Intervirology 9:106–118
    [Google Scholar]
16. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. 1988; Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
    [Google Scholar]
17. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of SciencesU.S.A. 74:5463–5467
    [Google Scholar]
18. Sato T. A., Hayami M., Yamanouchi K. 1981; Antibody response to structural proteins of measles virus in patients with natural measles and subacute sclerosing panencephalitis. Japanese Journal of Medical Science and Biology 34:365–373
    [Google Scholar]
19. Sato T. A., Fukuda A., Sugiura A. 1985; Characterization of major structural proteins of measles virus with monoclonal antibodies. Journal of General Virology 66:1397–1409
    [Google Scholar]
20. Sato T. A., Kohama T., Sugiura A. 1988; Intracellular processing of measles virus fusion protein. Archives of Virology 98:39–50
    [Google Scholar]
21. Sheppard R. D., Raine C. S., Bornstein M. B., Udem S. A. 1986; Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proceedings of the National Academy of SciencesU.S.A. 83:7913–7917
    [Google Scholar]
22. Ter Meulen V., Stephenson J. R., Kreth H. W. 1983; Subacute sclerosing panencephalitis. In Comprehensive Virology 18105–159 Fraenkel-Conrat H., Wagner R. R. New York: Plenum Press;
    [Google Scholar]
23. Ueda S., Okuno Y., Hamamoto Y., Ohya H. 1975; Subacute sclerosing panencephalitis (SSPE): isolation of a defective variant of measles virus from brain obtained at autopsy. Biken Journal 18:113–122
    [Google Scholar]
24. Wechsler S. L., Weiner H. L., Fields B. N. 1979; Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. Journal of Immunology 123:884–889
    [Google Scholar]
25. Wong T. C., Hirano A. 1987; Structure and function of bicistronic RNA encoding the phosphoprotein and matrix protein of measles virus. Journal of Virology 61:584–589
    [Google Scholar]